Merck
CN
Search Within
Document Type

540-97-6

Applied Filters:
Keyword:'540-97-6'
Showing 1-30 of 78 results for "540-97-6" within Technical Documents
ADP-ribosylcyclase (A8950) - Enzyme Assay
used 0.02 = Injection volume (in milliliter) for HPLC3 (Concentration of standard J�PO�GLYLGHG�E\�540 J/ PROH������� A =
Product Information Sheet - F6428
m-anisidine (ESPA) to produce a quinoneimine dye that shows an absorbance maximum at 540 nm.6,7 The increase in absorbance at 540 nm is directly proportional to the free glycerol concentration of the sample.
Product Information Sheet - FG0100
m-anisidine (ESPA) to produce a quinoneimine dye that shows an absorbance maximum at 540 nm.6,7 The increase in absorbance at 540 nm is directly proportional to the free glycerol concentration of the sample.
Product Information Sheet - TR0100
m-anisidine (ESPA) to produce a quinoneimine dye that shows an absorbance maximum at 540 nm.6,7 The increase in absorbance at 540 nm is directly proportional to triglyceride concentration of the sample.
BQP02 (BQP02)
acceptor. Ann. Clin. Biochem., 6, 24 (1969). 2. Barham, D., and Trinder, P., An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst, 97, 142 (1972). SG,RBG,MAM
Data Sheet - I6271
chromatography. Monoclonal Anti-IL-6 at 540 nm. Receptor is provided as a liquid in phosphate buffered saline to which no preservatives are added. Description IL-6 is a multifunctional cytokine, produced
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
1 106 – 221 pg/mL TNF β Control 1 108 – 225 pg/mL Control 2 539 – 1119 pg/mL Control 2 540 – 1121 pg/mL
Data Sheet - W0392
3. Prehoda, K.E., et al., Cell, 97, 471-480 (1999). 4. Prehoda, K.E., et al., Science, 290, 801-806 (2000). 5. Miki, H., et al., EMBO J., 17, 6932-6941 (1998). 6. Suetsugu, S., et al., Biochem.
Anti-BACE-2 N-terminus (43-60) antibody produced in rabbit (B7935)
Purification and cloning of amyloid precursor protein β-secretase from human brain., Nature, 402, 537-540 (1999). 8. Hussain, I., et al., Identification of a novel aspartic protease (Asp 2) as β-secretase
Product Information Sheet - N9389
-109 (1986). 4. Wei, J.S. et al., Clin. Chem., 39(3), 540-543 (1993). 5. Gioria, R. et al., Plant Pathology, 51, 127-133 (2002). 6. Owen, M.A.G. et al., Aquaculture, 344-349, 141-146 (2012
Product Information Sheet - CKH200A
to 450 nm. If wavelength correction is available, set to 540 nm or 570 nm. If wavelength correction is not available, subtract readings at 540 nm or 570 nm from the readings at 450 nm. This subtraction
Kits and Reagents for Metabolic and Dietary Research
o-Dianisidine ++ H2SO 4 Pink Color (540 nm ) O CH2OH OH OH OH OH Hexokinase PHO OH O O O CH2 OH OH
XP725 Antibody Number-Lot Number 071M4826
488 509 510 511 512 533 534 535 536 557 558 559 560 6.3 489 490 491 492 513 514 515 516 537 538 539 540 561 562 563 564 6.4 493 494 495 496 517 518 519 520 541 542 543
Anti-BACE-2 C-terminus (501-518) antibody produced in rabbit (B8060)
Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature, 402, 537-540 (1999). 8. Hussain, I., et al., Identification of a novel aspartic protease (Asp 2) as β-secretase
LABORATORY NOTEBOOK ISSUANCE PAGE
2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015 0.19 90 7 540 8 200 0.006 0.16 85 7 541 20–25 34 0.006 0.16 78 7 542
LABORATORY NOTEBOOK ISSUANCE PAGE
2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015 0.19 90 7 540 8 200 0.006 0.16 85 7 541 20–25 34 0.006 0.16 78 7 542
LABORATORY NOTEBOOK ISSUANCE PAGE
2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015 0.19 90 7 540 8 200 0.006 0.16 85 7 541 20–25 34 0.006 0.16 78 7 542
Product Information Sheet - CS0270
and Equipment required but not provided • Multiwell plate reader capable of readings between 540 and 570 nm • Recommended Sample Diluent, 50 mM phosphate, pH 6.0 • Calibrated adjustable precision
Product Information Sheet - FLSAR
Biochem., 204, 283-291 (1992). 17. Simpson, W.J., and Hammond, J.R.M., J. Biolum. Chemilum., 6, 97-106, (1991). 18. Kricka, L.J., Techniques, Clin. Chem., 37, 1472-1481 (1991). 19. Naderi, S.
Product Information Sheet - FLASC
Biochem., 204, 283-291 (1992). 17. Simpson, W.J., and Hammond, J.R.M., J. Biolum. Chemilum., 6, 97-106, (1991). 18. Kricka, L.J., Techniques, Clin. Chem., 37, 1472-1481 (1991). 19. Naderi, S.
Halal Certificate
UNDECADIEN-2-ONE 97% W354201 A94816 HC-23SIKX84 310. 6-AMYL-ALPHA-PYRONE 96%, FG W369608 B55311 HC-23SIUV28 311. 6-METHOXY-2,6-DIMETHYLHEPTANAL, STABILIZED W474505 D23352 HC-23SISD88 312. 6-METHYL-5-
Halal Certificate
UNDECADIEN-2-ONE 97% W354201 A94816 HC-22SI5S06 310. 6-AMYL-ALPHA-PYRONE 96%, FG W369608 B55311 HC-22SIVK49 311. 6-METHOXY-2,6-DIMETHYLHEPTANAL, STABILIZED W474505 D23352 HC-22SI6B10 312. 6-METHYL-5-
Protocol- HMYOMAG-56K
(n=6). Analyte Overnight Protocol 2 Hour Protocol % Recovery in Serum Matrix % Recovery in Serum Matrix Apelin 100 97 Fractalkine 97 88
Article: Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogs
秩和检验用于比较IL-2、IL-4、IL-6、IL-7、IL-8、IL-10、IL-13、IL-18、FOXP3、单 © 2018 ESVD and ACVD, Veterinary Dermatology8 Souza et al. https://baike.baidu.com/item/%E6%96%97%E7%89%9B%E6%A2%97 https://baike.
Mouse Angiogenesis /Growth Factor Magnetic Bead Panel
Angiopoietin-2 99 G-CSF 96 sFasL 98 sALK-1 98 Amphiregulin 97 Leptin 99 IL-1 99 Betacellulin 95 EGF 97 IL-6 97 Endoglin 100 Endothelin-1 104 FGF-2 100
Protocol- MAGPMAG-24K
Angiopoietin-2 99 G-CSF 96 sFasL 98 sALK-1 98 Amphiregulin 97 Leptin 99 IL-1b 99 Betacellulin 95 EGF 97 IL-6 97
Impurities & Related Compounds: Reference Materials
854863-55-1 105959-56-6 1368654-26-5 540-84-1 20535-83-5 149-57-5 345-92-6 874-43-1 51-78-5 123-42-2 103931-20-0 60-31-1 1466-82-6 530-75-6 121268-17-5 23828-
Protocol: Human Neurological Disorders Magnetic Bead Panel 3
Recovery SOD1 90% 108% 97% 97% Angiotensinogen 91% 109% 88% 88% Fetuin A 77% 103% 107% 92% SOD2 90% 100% 98% 97% Contactin-1 88% 105% 94% 99%
Protocol- HND3MAG-39K
Recovery SOD1 90% 108% 97% 97% Angiotensinogen 91% 109% 88% 88% Fetuin A 77% 103% 107% 92% SOD2 90% 100% 98% 97% Contactin-1 88% 105% 94% 99% Kallikrein-6
Protocol: Human Immuno-Oncology Checkpoint Protein Panel 1
CD27 96 CD28 95 TIM-3 98 HVEM 98 CD40 97 GITR 90 LAG-3 97 TLR-2 95 GITRL 103 PD-1 97 CTLA-4 95 CD80/B7-1 96 CD86/B7-2 98
Page 1 of 3